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Abstract
Introduction:  Patients  with  end  stage  liver  disease  (ESLD)  referred  for  liver  transplantation  (LT)
are forwarded  to  pulmonary  evaluation  before  being  operated.  ESLD  is  associated  with  muscle
wasting, reduced  exercise  tolerance  and  aerobic  capacity.
Objectives:  We  assessed  the  association  between  aerobic  capacity  (AC),  liver  disease  severity
and postoperative  LT  outcomes  in  a  series  of  LT  candidates  in  a  university  afﬁliated  hospital  in
Brazil.
Methods: Pre-LT  oxygen  uptake  at  peak  (pre-VO2peak),  liver  disease  severity,  and  early  pos-LT
outcomes such  as  length  of  intensive  care  unit  (ICU)  stay,  <5  and  ≥5  days  and  hospitalization,  <20
and ≥20  days  and  postoperative  mortality  were  compared.  Pre-VO2peak was  measured  through
the cardiopulmonary  exercise  testing  (CPET).  Severity  of  liver  disease  was  estimated  by  the
Model for  End-Stage  Liver  Disease  (MELD)  categorization  into  MELD  <  18  and  MELD  ≥  18  groups.
Student’s  t-test  was  used  to  compare  these  groups.  A  logistic  regression  model  was  built  to
verify the  effect  of  those  variables  on  the  length  of  ICU  stay,  length  of  hospitalization  and
postoperative  mortality.
Results:  A  total  of  47  patients  were  include  in  analysis.  Pre-VO2peak was  similar  to  that  ofls  (75  ±  18%)  and  worse  in  the  MELD  ≥  18  group  as  compared  to  the
87  vs  25.21  ±  8.76  mL/kg/min,  respectively;  p  =  0.048).  According  to
nly  a  lower  pre-VO2peak (<20.09  ±  4.83  mL/kg/min)  was  associated
talization  (p  =  0.01).healthy sedentary  individua
MELD <  18  group  (19.51  ±  7.
the multivariate  analysis,  o
to a  greater  length  of  hospi∗ Corresponding author.
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Conclusions:  In  LT  candidates,  a  reduced  pre-VO2peak may  predict  a  higher  risk  of  greater  pos-LT
length of  hospitalization.  The  length  of  ICU  stay  and  postoperative  mortality  were  not  associated
with variables  studied.  This  ﬁnding  should  be  evaluated  in  other  studies  before  making  speciﬁc
recommendations  about  a  routine  use  of  CPET  in  LT  candidates.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALAVRAS-CHAVE
Doenc¸a Hepática
Terminal;
Prova  de  Esforc¸o;
Tolerância  ao
Exercício;
Transplante  de  Fígado
Avaliac¸ão  da  tolerância  ao  exercício  físico  antes  e  após  transplante  hepático  e
inﬂuência  do  treinamento  supervisionado
Resumo
Introduc¸ão:  Pacientes  com  doenc¸a  hepática  em  estágio  ﬁnal  (DHEF),  referenciados  para  trans-
plante hepático  (TH),  são  encaminhados  para  avaliac¸ão  da  func¸ão  pulmonar  antes  de  serem
operados. DHEF  está  associada  à  fraqueza  muscular,  reduc¸ão  da  tolerância  ao  exercício  e
capacidade  aeróbica  (CA).
Objetivos:  Foi  avaliada  a  associac¸ão  entre  capacidade  aeróbica,  a  gravidade  da  doenc¸a  hep-
ática e  os  resultados  pós-operatórios  do  TH  em  uma  serie  de  candidatos  a  TH  em  um  hospital
universitário  no  Brasil.
Métodos:  O  consumo  de  oxigênio  num  teste  limitado  por  sintomas  (VO2pico)  pré-TH,  a  gravidade
da doec¸a hepática,  e  os  resultados  precoces  pós-TH  como  tempo  de  permanênica  na  unidade
de cuidados  intensivos  (UCI),  <5  e  ≥5  dias,  tempo  de  permanência  hospitalar,  <20  e  ≥20  dias
e mortalidade  foram  comparados.  O  VO2pico pré-TH  foi  medido  através  do  teste  de  exercício
cardiopulmonar  (TECP).  A  gravidade  da  doenc¸a  hepática  foi  estimada  pelo  Modelo  para  doenc¸a
hepática em  estágio  ﬁnal  [Modelo  de  End-Stage  Liver  Disease  (MELD)]  e  categorizada  nos  grupos
MELD <  18  e  MELD  ≥  18.  O  teste  t  de  Student  foi  utilizado  para  comparar  esses  grupos.  Um  modelo
de regressão  logística  foi  construido  para  veriﬁcar  o  efeito  dessas  variáveis  sobre  o  tempo  de
permanência  na  UTI,  tempo  de  internac¸ão  e  mortalidade  pós-operatória.  Resultados:  um  total
de 47  pacientes  foram  incluídos  nas  análises.  O  VO2pico pré-TH  foi  semelhante  ao  de  indivíduos
saudáveis  sedentários  (75  ±  18%)  e  pior  no  grupo  MELD  ≥  18  em  comparac¸ão  com  o  MELD  <  18
(19.51 ±  7.87  vs  25.21  ±  8.76  mL/kg/min,  respectivamente;  p  =  0.048).  De  acordo  com  a  análise
multivariada,  somente  um  menor  VO2pico (<20.09  ±  4.83  mL/kg/min)  pré-TH  foi  associado  a  um
maior tempo  de  internac¸ão  (p  =  0,01).
Conclusão:  Em  candidatos  a  TH,  uma  reduc¸ão  do  VO2pico pré  pode  predizer  um  maior  risco  de
maior permanência  hospitalar  pós-TH.  Esta  constatac¸ão  deve  ser  avaliada  em  outros  estudos
antes de  fazer  recomendac¸ões  especíﬁcas  sobre  o  uso  rotineiro  do  TECP  para  candidatos  TH.
O tempo  de  permanência  na  UTI  e  mortalidade  pós-operatória  não  foram  associados  com  as
variáveis  estudadas.
©  2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Este  é
um artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/licenses/
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. Introduction
iver  transplantation  (LT)  is  largely  indicated  for  patients
ith  end-stage  liver  diseases  (ESLD).1 The  proportion  of
atients  for  whom  this  therapy  has  been  indicated  has
ncreased  worldwide,  although  the  number  of  viable  grafts
as  not  in  the  same  proportion.2 Due  to  this  discrepancy,  sev-
ral  scores  has  been  developed  in  order  to  better  assess  the
everity  of  ESLD.  Previous  studies  had  shown  that  the  Model
or  End-Stage  Liver  Disease  (MELD)  --  the  most  used  one  --
as  a  strong  association  with  pre-transplant  mortality  rate.3
n  spite  of  that,  it  does  not  accurately  predict  complications
fter  LT.4The  amelioration  of  operative  techniques  and  the  recent
dvances  in  the  immunosuppressive  therapy  has  consis-
ently  contributed  to  the  better  rates  of  survival  and
a
A
ahe  prevention  of  graft  dysfunction.  Although  LT  success
s  traditionally  measured  using  variables  related  to  graft
unction  along  with  patient  survival,  it  may  be  accounted
n  terms  of  health-related  quality  of  life  scores  or  even
hrough  cardiopulmonary  parameters  such  as  aerobic  capac-
ty  (AC),  exercise  capacity,  skeletal  muscle  strength  and
ody  composition.5--7
An  effective  interaction  of  several  physiologic  mecha-
isms  is  necessary  to  sustain  exercise  and  maintain  gas
xchange  between  the  environment  and  the  cells.8 The
old  standard  for  AC  analysis  is  the  oxygen  uptake  at  peak
xercise  (VO2peak)  during  symptom-limited  cardiopulmonary
xercise  testing  (CPET).  CPET  provides  an  integrated  evalu-
tion  of  muscle  and  cardiorespiratory  responses  to  effort.9
C  has  been  used  as  a  prognostic  factor  in  LT  and  is  associ-
ted  with  liver  disease  severity  as  measured  by  MELD.5,6 AC
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is  reduced  in  patient  with  chronic  liver  disease  by  several
mechanisms:  metabolic  disorders,  malnutrition,  decreased
muscle  strength,  cirrhotic  cardiomyopathy  and  anemia.10--13
Evaluation  of  VO2peak before  LT  may  be  useful  in  pro-
gnostic  evaluation  and  for  the  prescription  of  supervised
exercise  programs  in  both  pre-  and  postoperative  periods,
thus  increasing  the  possibility  of  restoring  the  AC  of  these
individuals.13--15
Therefore,  the  aim  of  this  study  is  to  verify  the  associ-
ation  between  AC  and  the  severity  of  liver  disease  (MELD)
and  its  relation  to  the  immediate  clinical  outcomes  after  LT:
length  of  ICU  stay  and  of  hospitalization  and  postoperative
mortality.
2. Materials and methods
This  is  a  transversal  study.  Patients  aged  more  than  18  years
who  were  active  on  the  LT  list  and  were  undergoing  regular
monitoring  at  the  outpatient  clinic  of  the  Liver  Transplan-
tation  Unit  of  Clinics  Hospital  of  the  Federal  University  of
Minas  Gerais  were  invited  to  participate  in  the  study  from
May  2010  to  October  2011.
Patients  who  were  on  the  waiting  list  to  undergo  liver
re-transplantation,  those  who  were  hospitalized  at  the  time
of  enrollment,  those  who  had  moderate-to-severe  hepatic
encephalopathy  or  were  unable  to  perform  the  CPET,  and
those  with  indication  for  combined  transplant  (liver  plus
another  organ)  were  excluded  from  the  study.
In  the  ﬁrst  visit,  data  from  the  physical  examination,
anthropometric  data,  comorbidities,  medicines  in  use,  and
calculation  of  the  Child-Turcotte-Pugh  (CHILD)  score  and
MELD  classiﬁcations  were  performed.
Patients  included  in  the  study  were  classiﬁed  into  groups
MELD  <18  or  ≥18.  After  transplantation  length  of  ICU  stay
and  length  of  hospitalization  were  assessed  and  grouped  in
<5  and  ≥5  days  and  <20  or  ≥20  days,  respectively.
CPET  tests  were  performed  according  to  interna-
tional  guidelines9 using  an  integrated  stationary  metabolic
ErgoPC  Elite  system  for  effort  and  metabolic  gas  anal-
ysis  (Micromed,  Brasilia,  Brazil;  expired  gas  analyzer:
MetaLyzer® 3B  Cortex,  Cortex,  Leipzig,  Germany).  All  equip-
ments  were  calibrated  before  all  examinations.  On  a
treadmil,  individualized  speed  ramp  protocol  was  used  and
the  duration  of  the  test  was  limited  by  maximal  exertion
or  if  safety  criteria  were  fulﬁlled.  Maximal  exertion  was
deﬁned  as  a  failure  to  maintain  the  ergometer  speed  for
more  than  30  seconds  or  the  development  of  symptoms  of
fatigue,  pain  or  lightheadedness.9 One  single  professional
conducted  the  tests,  but  the  records  were  analyzed  inde-
pendently  by  two  professionals  using  the  Metasoft® Cortex
software  (Cortex,Leipzig,  Germany).
In  the  case  of  divergence  between  the  reports,  the
records  were  re-analyzed  together  by  both  professionals  in
order  to  reach  a  consensus.
The  minute  ventilation,  respiratory  rate,  tidal  volume,
oxygen  uptake  at  peak  exercise  during  symptom-limited
CPET  --VO2peak,  carbon  dioxide  production  (VCO2),  venti-
latory  equivalents  (VE/VO2 and  VE/VCO2),  and  end  tidal
pressure  (PETO2 and  PETCO2)  were  measured  using  face
masks  that  allowed  the  passage  of  exhaled  air  in  breath-
to-breath  intervals  with  a  cut-off  point  every  15  seconds  for
a
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nalysis.  The  VO2peak was  considered  according  to  the  aver-
ge  of  the  last  30  seconds  of  exercise  that  was  interrupted
y  signs  of  maximum  effort  tolerance:  exhaustion,  fatigue
r  lower  limb  pain  that  prevented  continuation  of  the  exer-
ise.  The  anaerobic  threshold  (AT)  was  determined  using
he  visual-graphic  method  (V-slope  method)  and  the  tabular
ethod.9 In  addition  to  the  values  provided  by  Metasoft,  the
O2-predicted  percentage  of  sedentary  healthy  individuals
as  calculated  using  the  formula  proposed  by  Bruce  et  al.16
he  VO2 in  the  AT  was  presented  as  absolute  values  and  as
ercentage  of  the  predicted  VO2.
Descriptive  results  were  presented  as  absolute  values
nd  relative  frequency  for  the  characteristics  of  various
ualitative  variables  (i.e.,  death,  gender,  and  etiology  of  cir-
hosis)  and  of  the  computation  of  arithmetic  mean,  median,
tandard  deviation,  and  interquartile  interval  for  the  follow-
ng  quantitative  traits:  age,  MELD  and  CHILD  scores,  length
f  ICU  stay,  length  of  hospitalization,  VO2peak,  %predicted
O2peak, VO2 in  AT,  and  VO2 in  %predicted  AT.
All  analyzed  data  were  assessed  using  the  Shapiro--Wilk
est  in  order  to  evaluate  the  normality  of  data  distribution.
or  comparisons  between  MELD  <18  and  MELD  ≥18  groups,
he  Mann--Whitney  test  or  Student’s  t-test  for  independent
amples  was  used.  A  statistical  signiﬁcance  level  of  0.05  was
dopted  for  those  analyses.  A  logistic  regression  model  was
sed  to  verify  the  effect  or  inﬂuence  of  each  variable  on
he  length  of  ICU  stay  (<5  or  ≥5  days)  and  length  of  hos-
italization  (<20  or  ≥20  days)  and  postoperative  mortality.
nly  patients  who  had  performed  the  CPET  less  than  90  days
efore  LT  and  had  not  died  in  the  operative  room  were  con-
idered  for  analyses.  All  variables  that  were  signiﬁcant  at
he  level  of  0.25  were  regarded  as  candidate  variables  for
he  multivariate  model,  except  for  those  that  were  a  lin-
ar  combination  of  other  variables,  i.e.,  age,  sex,  and  VO2
n  the  %  predicted  AT.  The  covariables  that  independently
ad  a  p-value  <0.05  were  maintained  for  the  next  stage.  For
tatistical  analyses,  the  following  programs  were  used:  Sta-
istical  Package  for  the  Social  Sciences,  version  17.0  (SPSS
nc.,  Chicago,  IL,  USA)  and  R  Development  Core  Team  2010
R  Foundation  for  Statistical  Computing,  Vienna,  Austria).
All  the  participants  agreed  to  participate  and  signed  the
nformed  consent  form.  The  study  protocol  and  the  informed
onsent  form  were  approved  by  the  Research  Ethics  Commit-
ee  of  Federal  University  of  Minas  Gerais  (document:  ETIC
o.  134/09,  dated  May  29,  2009).
.  Results
etween  May  2010  and  October  2011,  111  patients  under-
ent  LT  in  our  hospital;  of  these,  47  patients  participated
n  this  study  and  performed  CPET  before  LT.  Sixteen
atients  don’t  meet  the  inclusion  criteria  (4  due  to  com-
ined  transplant  (liver-kidney),  5  were  hospitalized,  4  with
oderate-to-severe  hepatic  encephalopathy  and  3 were
ot  able  to  perform  the  CPET).  In  the  remaining  48,  the
PET  was  temporarily  unavailable.  As  two  patients  did  not
each  the  AT  during  CPET,  two  died  during  the  perioper-
tive  period,  and  one  had  performed  CPET  more  than  90
ays  before  LT,  the  length  of  ICU  stay  in  the  ICU  of  hos-
italization  could  be  assessed  in  only  42  patients.  Patients
haracteristics  and  outcomes  are  shown  in  Table  1.
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Table  1  Clinical  and  demographic  characteristics  of
patients  undergoing  liver  transplantation  in  the  study.
Variables  Results  (n  =  47)
Sex,  n  (%)  Men  29  (61.7)
Women  18  (38.3)
BMI, kg/m2,
Mean  ±  SD
27.54  ±  4.66
Age, years,
Mean  ±  SD
54  ±  19
MELD,  n  (%)  <18  30  (63.8)
≥18 17  (36.2)
CHILD,  n  (%) A  8  (17.0)
B 19  (40.4)
C 20  (42.6)
Etiology  of  liver
cirrhosis,  n  (%)
HCV  10  (18.5)
HBV  6  (11.1)
Alcoholism  15  (27.8)
Tumor  8  (14.8)
Other  15  (27.8)
Pos operative
mortality,  n  (%)
6  (12.8)
1--30 days  2  (4.3)
31--90 days  2  (4.3)
>90 days  2  (4.3)
Length  of
hospitalization,
n (%)
<20  days  20  (48)
(n =  42) ≥20  days 22  (52)
Length  of  ICU  stay,
n (%)
<5  days 20  (48)
(n =  42)  ≥5  days  22  (52)
BMI: body mass index; SD: standard deviation; MELD: Model
for End-Stage Liver Disease; Child: Child-Turcotte-Pugh; HCV:
hepatitis C virus; HBV: hepatitis B virus; Other: primary biliary
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dcirrhosis, hemochromatosis, Caroli disease, cryptogenic cirrho-
sis; Tumor: hepatocellular carcinoma or hemangioendothelioma;
ICU: Intensive Care Unit.
There  were  no  adverse  events  during  CPET  tests.  We  ana-
yzed  45  patients  because  two  patients  did  not  reach  the  AT.
n  this  sample,  VO2peak values  were  similar  to  those  predicted
or  healthy  sedentary  individuals,  although  they  presented
igh  percentage  of  VO2peak values  even  during  submaximal
ffort  (Table  2).
Patients  who  underwent  both  LT  and  CPET  were  ana-
yzed  according  to  the  cirrhosis  severity:  MELD  <  18  group
Table  2  Aerobic  capacity  of  45  patients  who  have  per-
formed  CPET.
Variable  Values
VO2peak,  %  predicted,  Mean  ±  SD  0.75  ±  0.18
VO2 in  AT,  mL/kg/min,  Mean  ±  SD  16.37  ±  4.42
VO2 AT,  %  predicted,  Mean  ±  SD  0.72  ±  0.12
VO2peak,  mL/kg/min,  Mean  ±  SD  22  ±  10.16
CPET: cardiopulmonary exercise testing; SD: standard deviation;
VO2peak: oxygen uptake at peak exercise; AT: anaerobic thresh-
old.
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22  patients)  and  MELD  ≥  18  group  (23  patients;  Table  3).
O2peak was  signiﬁcantly  higher  in  MELD  <  18  group.  In  the
valuation  of  AC,  regardless  of  MELD,  patients  reached,  on
verage,  over  70%  of  the  VO2peak value  (Table  3).
The  univariate  analysis  is  presented  in  Table  4. One
atient  who  underwent  CPET  more  than  90  days  before  the
T  and  two  patients  who  died  during  the  perioperative  phase
ere  excluded  from  this  evaluation.  The  sample  consisted
f  22  patients  in  the  ≥20-day  hospitalization  group  and  20
atients  in  the  <20-day  hospitalization  group.  The  variables
O2peak,  mL/kg/min,  VO2peak/VO2peak predicted  and  VO2in AT,
L/kg/min  were  signiﬁcant  in  the  univariate  analysis  and
ere  selected  for  multivariate  analysis.
The  multivariate  regression  model  is  presented  in  Table  5.
he  only  variable  that  remained  signiﬁcant  for  the  length
f  hospitalization  was  the  VO2peak (mL/kg/min).  The  risk  of
eing  hospitalized  for  more  than  20  days  decreases  by  0.20
s  the  VO2peak increases  by  1  mL/kg/min.  There  were  not
ound  any  variables  independently  associated  to  length  of
CU  stay  and  postoperative  mortality  in  the  ﬁnal  model.
. Discussion
he  main  results  of  this  study  were  that  patients  in  the
aiting  list  of  LT,  the  AC  as  measured  by  the  VO2peak was
omparable  to  that  of  healthy  sedentary  individuals,  AC  was
orse  in  the  MELD  ≥18  group,  and  an  inverse  relationship
etween  length  of  hospitalization  and  VO2peak was  observed.
Patients  with  ESLD  have  several  factors  that  may  lead
o  exercise  limitation.  The  liver  is  the  main  organ  involved
n  carbohydrate  homeostasis.17--20 Moreover,  these  patients
ay  have  a  resting  hyperdynamic  cardiovascular  state,  char-
cterized  by  a  decrease  in  pulmonary  vascular  resistance
ssociated  with  increased  cardiac  frequency  and  cardiac
ndex.11,21,22 All  of  these  factors  may  contribute  to  disor-
anization  of  the  muscular,  pulmonary  and  cardiovascular
omponents  of  exercise  capacity  and  may  lead  to  a  reduced
O2peak.13 These  factors  may  explain  the  lower  VO2peak found
n  our  study,  in  which  patients  had  severe  disease  (MELD
18).  This  result  is  concordant  with  that  of  Dharancy  et  al.
hat  reported  a  negative  correlation  between  VO2peak and
ELD.12 Lemyze  et  al.  also  found  that  the  severity  of  the
isease,  as  determined  by  MELD  score,  was  an  indepen-
ent  variable  more  closely  associated  with  the  changes  in
O2peak23. Two  other  studies  also  found  a  signiﬁcant  negative
orrelation  between  severity  of  ESLD  (CHILD  classiﬁcation)
nd  the  AC.24,25
During  submaximal  effort,  the  VO2peak of  the  sample  was
6.37  ±  4.4  mL/kg/min.  However,  the  MELD  ≥18  group  had
ower  values  (median  ±  II:  14.83  ±  3.7  mL/kg/min),  although
e  did  not  ﬁnd  a  signiﬁcant  difference  between  the
roups.  In  a  study  carried  out  by  Pieber  et  al.,  the  aver-
ge  value  of  VO2peak found  in  the  patients  before  LT  was
0.3  ±  3 mL/kg/min.  Nevertheless,  they  did  not  refer  to  any
core  of  severity  of  the  disease.10
CPET  represents  the  gold  standard  for  the  determination
f  exercise  capacity  and  cardiorespiratory  reserve,  which
eﬂects  the  ability  of  the  body  to  consume  and  use  oxygen
uring  exercise.9 In  disagreement  with  all  the  current  evi-
ence,  in  our  study,  the  patients  showed  a VO2peak similar  to
hat  of  sedentary  healthy  individuals.  The  reasons  that  could
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Table  3  Aerobic  capacity  of  patients  in  groups  categorized  by  MELD  (n  =  45).
Aerobic  capacity  MELD  <18  group  MELD  ≥18  group  P  value
VO2peak,  mL/kg/min  (Mean  ±  SD)  25.21  ±  8.76  19.51  ±  7.87  0.048a
VO2peak,  %  predicted  (Mean  ±  SD)  0.80  ±  0.19  0.71  ±  0.17  0.109a
VO2 in  AT,  mL/kg/min  (Mean  ±  SD) 17.34  ±  5.65 14.83  ±  3.7 0.100a
VO2 in  AT,  %  predicted  (Mean  ±  SD) 0.70  ±  0.12 0.74  ±  0.13 0.354a
MELD: Model for End-Stage Liver Disease; SD: standard deviation; VO2peak: oxygen uptake at peak exercise; AT: anaerobic threshold.
a Student’s t-test.
Table  4  Univariate  analysis  of  the  quantitative  variables  and  length  of  hospitalization  (n  =  42).
Variables Hospitalization  <20  days
Mean  ±  SD
Hospitalization  ≥20  days
Mean  ±  SD
  CI  95%    P  value
VO2peak,  mL/kg/min  27.72  ±  8.22  20.09  ±  4.83  −0.20  −0.35;  −0.04  0.011
VO2peak/VO2max predicted  0.84  ±  0.18  0.71  ±  0.21  −3.40  −6.91;  0.48  0.086
VO2in AT,  mL/kg/min  17.84  ±  4.57  15.47  ±  3.67  −0.15  −0.34;  0.04  0.123
VO2 AT/VO2peak* 0.66  ±  0.11  0.78  ±  0.12  NA  NA  NA
Age* 49.81  ±  13.32  55.86  ±  11.87  0.04  −0.01;  0.09  0.134
MELD 16.57  ±  5.03  17.24  ±  4.41  0.03  −0.09;  0.16  0.642
CHILD 8.86  ±  2.41  8.90  ±  1.81  0.01  −0.28;  0.30  0.941
NA: was not able to adjust in the univariate analysis; SD: standard deviation; VO2peak/VO2max predicted: relationship between O2
consumption at peak exercise and the consumption predicted for healthy sedentary individuals; VO2 AT: O2 uptake in anaerobic threshold;
VO2 AT/VO2peak: O2 uptake anaerobic threshold regarding the peak consumption; OR: odds ratio; : beta coefﬁcient; CI 95% : conﬁdence
ase; 
odel.
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einterval of beta coefﬁcient; MELD: Model for End-Stage Liver Dise
* Variables with multicollinearity that was not included in the m
explain  this  ﬁnding  are  not  known  and  should  be  addressed
in  other  studies.
In this  study,  multivariate  analysis  showed  an  inde-
pendent  association  between  AC  and  the  length  of
hospitalization.  A  similar  result  was  observed  by  Bernal  et  al.
in  the  patients  with  impaired  AC  who  had  prolonged  hospi-
talization  after  LT.  The  results  of  the  present  study  suggest
that  the  patient’s  evaluation  by  means  of  CPET  before  LT
may  contribute  to  the  prediction  of  some  outcomes  after  LT.
Moreover,  CPET  may  reﬂect  the  stress  caused  by  LT  and  may
successfully  reveal  the  conditions  that  could  compromise
the  ﬁnal  result  of  an  LT,  such  as  coronary  heart  disease  and
pulmonary  hypertension.14,26
We  did  not  ﬁnd  any  relevant  associated  variables  with
length  of  ICU  stay.  It  is  well  known  that  patients  with
reduced  cardiorespiratory  reserve  have  an  ICU  stay  with  a
mean  of  5.3  days  longer  as  compared  to  patients  with  nor-
mal  cardiorespiratory  reserve,  a  ﬁnding  that  is  important
in  terms  of  critical  care  management  and  costs  of  medical
assistance.26 Otherwise,  the  prediction  of  early  postopera-
tive  mortality  is  particularly  important  in  the  context  of  LT
l
t
a
t
Table  5  Final  model  of  logistic  regression  to  explain  the  length  o
Characteristics  Hospitalization
<20  days
Mean  ±  SD
Hospitaliz
≥20  days
Mean  ±  SD
VO2peak,  mL/kg/min  27.72  ±  8.22  20.09  ±  4.
P value = 0.941 of the Hosmer--Lemeshow Test of Goodness of Fit; SD
interval of beta coefﬁcient at 95%; VO2peak: oxygen uptake at peak exeChild: Child-Turcotte-Pugh.
s  the  appropriate  allocation  of  limited  donor  organs  and
more  recently)  marginal  grafts  is  critical.  Prentis  et  al.
ave  demonstrated  that  a  cardiopulmonary  reserve  of  more
han  9.0  mL/min/kg  predicted  reliably  a  reduced  postopera-
ive  mortality  risk.26 Regarding  this  topic,  our  multivariate
nalysis  of  postoperative  mortality  didn’t  show  any  signif-
cant  associated  variables.  It  should  be  emphasized  that
he  observed  postoperative  mortality  in  our  sample  was  too
mall  (only  two  deaths).
This  research  was  innovative  in  that  it  revealed  the  real
hysical  condition  of  the  patients  who  were  candidates  for
T  in  our  hospital.  No  adverse  events  were  observed  dur-
ng  the  examinations;  this  had  not  been  expected  because
ur  patients  were  at  high  risk  of  having  complications  in
readmill  tests.
Among  our  limitations,  the  low  sample  size  is  partly
xplained  by  the  reduced  number  of  patients  on  the  waiting
ist  for  LT  in  the  State  of  Minas  Gerais,  Brazil,  at  the  time  of
his  study.  Moreover,  since  the  test  was  temporarily  unavail-
ble,  we  fail  to  perform  48  tests  of  patients  who  were  able
o  transplant.  This  is  because  TCP  is  not  routinely  performed
f  hospitalization  (n  =  42).
ation   CI  95%    P  value
83  −0.20  −0.35;  −0.04  0.011
: standard deviation; : beta coefﬁcient; CI 95% : conﬁdence
rcise.
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22  
y  these  patients  and  is  not  a  recommendation  of  the  local
rotocol  LT  in  our  hospital.  The  number  of  prospective  stud-
es  comparing  LT  outcomes  with  AC  is  low.  Therefore,  it  is
ifﬁcult  to  compare  our  results  with  the  available  reports  in
he  medical  literature.
In  conclusion,  in  LT  candidates,  a  reduced  pre-VO2peak
ay  predict  a  higher  risk  of  greater  pos-LT  length  of  hospital-
zation.  The  length  of  ICU  stay  and  postoperative  mortality
ere  not  associated  with  variables  studied.  This  ﬁnding
hould  be  evaluated  in  other  studies  before  making  spe-
iﬁc  recommendations  about  a  routine  use  of  CPET  in  LT
andidates.
. Summary box
PET  represents  the  gold  standard  for  the  determination
f  exercise  capacity  and  cardiorespiratory  reserve,  and  it
enerates  measures  of  a  number  of  aspects  of  AC.
Chronic  liver  disease  is  associated  with  muscle  wasting,
educed  exercise  tolerance  and  AC.
The  VO2peak was  signiﬁcantly  higher  in  the  MELD  <18
roup.
The  patients  showed  an  AC  closer  to  that  of  healthy  indi-
iduals;  however,  those  with  poorer  performance  in  CPET
ad  a  higher  risk  of  greater  length  of  hospitalization.
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